China · Delayed Price · Currency is CNY Tibet AIM Pharm. Company Description
Tibet AIM Pharm. Inc. engages in the research and development, manufacturing, and sale of medical products in China. The company’s products include Miglitol tablets for diabetes; ethnic medicine products, suitable for treating breast lobular hyperplasia, uterine fibroids, and ovarian cysts; gynecology and obstetrics; and NalMefene hydrochloride injection for various acute poisoning, such as alcohol, organic phosphor, CO, sedative-hypnotic, opioid substance, severe infection, shock, cord injury, and brain, as well as coma, spinal cord injury, cerebral infarction, hemorrhage, etc. It also provides Carbetocin injections for prevention of postpartum hemorrhage; Domperidone tablets for treatment of indigestion, abdominal bloating, belching, nausea, vomiting, and abdominal distension and pain; Montmorillonite powder for chronic diarrhea; Hongjin Xiaojie tablets and Aceclofenac Enteric-Coated tablets, as well as for the treatment of antibiotics, antiallergic, and digestive systems.
Tibet AIM Pharm. Inc. was founded in 2003 and is based in Chengdu, China.
| Country | China |
| Founded | 2003 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 403 |
| CEO | Zhou Min |
Contact Details
Address: Liangjiang International Building B Chengdu, 610000 China | |
| Phone | 86 10 5873 1208 |
| Website | emyy.cn |
Stock Details
| Ticker Symbol | 002826 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100002C39 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Zhou Min | GM, Chief Financial Officer and Director |
| Qianjin Li | Deputy GM and Secretary of the Board of Directors |
| Ying Gao | Deputy General Manager |
| Huaming Jiang | Deputy General Manager |
| Yongxiang Zhang | Accounting Supervisor |
| Lian Yang | Deputy General Manager |
| Jing Sheng Cui | Deputy General Manager |